Campaigns
18 Nov 2026

Prostate United match kicks off parliamentary discussion on PSA tests

Recently, questions about prostate cancer deaths have been answered in the House of Commons, and a discussion about much-needed early detection was raised in parliament too. It's vital that men's voices are heard at the highest level, where decisions that can affect millions of lives are made.

MPs ask the Government about prostate cancer deaths

On 20 October, Chris Vince MP stood up in the House of Commons and asked the Government an important question: what else can be done to stop men dying from prostate cancer? 

Speaking to Health Minister James Frith MP, he highlighted how many men are still dying from the disease and why we need to do more to encourage men to come forward for testing. He also raised the inequalities affecting men from ethnic minority communities, before asking: 

"What can the Government do to support wonderful charities such as Prostate Cancer UK to cut the number of men dying of prostate cancer?"
Chris Vince Member of Parliament for Harlow

Earlier that day, Chris Vince MP and the Football Club All-Party Parliamentary Group had played a football match against a Prostate Cancer UK team of staff, celebrities and supporters. The match gave us a chance to speak directly with MPs about prostate cancer and why things need to change. 

261020 Parliament TOM MILES 0095 Small

And just hours later, those conversations reached the House of Commons. Every opportunity to speak up about prostate cancer is another chance to get the Government listening. 

So, what did the Government say about PSA testing?   

In his response, James Frith MP addressed something that's caused a lot of confusion recently: whether men can still ask their GP for a PSA blood test.   

Over the summer, some inaccurate news reports left men and their loved ones worried that the rules around PSA testing had changed and that they could no longer speak to their GP about getting tested. The Minister clarified that men who suspect they have symptoms can still raise these concerns with their GP and request a test.  

Six days later at a debate on prostate cancer screening, the Government further clarified that men without symptoms an ask their GP about a PSA test and make an informed choice, based on good-quality information, about the likelihood of being helped or being harmed. 

While we’re pleased the Government has set the record straight, more must be done to ensure men get the early diagnoses they deserve. Most men with early prostate cancer don't have symptoms. So it is vital that men understand their risk of prostate cancer, whether or not they have symptoms, and feel confident talking to their GP about any concerns. Our 30-second online Risk Checker has already helped over five million men understand their risk; try it here. 

What about prostate cancer screening?   

Just a few days later, on 26 October, prostate cancer was back on Parliament's agenda. This time, MPs debated a petition signed by nearly 140,000 people, calling for a national prostate cancer screening programme – starting with men at higher risk.   

At the debate MPs considered the National Screening Committee’s recent recommendation against a broad national screening programme for prostate cancer. 

The debate gave MPs another chance to ask the Government about earlier diagnosis and what needs to happen next. Although no decision was made to introduce a wider screening programme, it was another important opportunity to keep prostate cancer in the spotlight.   

Why don't we have a screening programme yet?   

In May 2026, the UK National Screening Committee (NSC) updated its latest recommendations on prostate cancer screening.   

After reviewing the evidence, it recommended regular PSA blood tests every two years for men aged 45–61 who have a BRCA2 gene variant and a family history of certain cancers, including prostate cancer.   

 It's a step forward for those men, but it leaves other high-risk groups, like Black men and men with a family history without a screening programme.  

Our groundbreaking TRANSFORM trial aims to find the best ways to screen men for prostate cancer and to produce the evidence the UK NSC needs to change its decision. The Government has agreed to invest an additional £18 million into TRANSFORM to make it the most representative prostate cancer screening trial the UK has ever seen.  

We're making progress. But we won't stop pushing for a future where more men get the chance of an earlier diagnosis.   

Donate to support our lifesaving work like TRANSFORM today.  

Donate today

202010 George Seed Researcher

How our research is making a difference

Over the last 25 years, our research, funded by supporters like you, has changed the lives of men with prostate cancer. From transforming the way prostate cancer is diagnosed to developing the first precision medicine for advanced prostate cancer, we've made this happen together.
The impact of research
2023-adobestock-test-tube-research-science

Donate

With your help we can beat prostate cancer, together.
Donate now